{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:34:12Z","timestamp":1761294852669,"version":"3.44.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Shandong","award":["ZR2019PH095"],"award-info":[{"award-number":["ZR2019PH095"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03903-1","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:19:38Z","timestamp":1752157178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Construction of a column-line graphical model of poor outcome of neoadjuvant regimens for muscle-invasive bladder cancer based on NLR, dNLR and SII indicators"],"prefix":"10.1186","volume":"23","author":[{"given":"Bo","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanna","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"4","key":"3903_CR1","first-page":"e59299","volume":"16","author":"MA Avci","year":"2024","unstructured":"Avci MA, Arslan B, Arslan O, et al. The role of thrombocyte\/lymphocyte ratio and aspartate transaminase\/alanine transaminase (De Ritis) ratio in prediction of recurrence and progression in Non-muscle invasive bladder Cancer [J]. Cureus. 2024;16(4):e59299.","journal-title":"Cureus"},{"issue":"2","key":"3903_CR2","doi-asserted-by":"publisher","first-page":"100416","DOI":"10.1016\/j.esmoop.2022.100416","volume":"7","author":"N Beije","year":"2022","unstructured":"Beije N, de Kruijff IE, de Jong JJ, et al. Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer [J]. ESMO Open. 2022;7(2):100416.","journal-title":"ESMO Open"},{"issue":"6","key":"3903_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1159\/000528740","volume":"107","author":"D BOLAT","year":"2023","unstructured":"BOLAT D, BALTACI S, AKGUL M, et al. Predictive role of the systemic immune inflammation index for intravesical BCG response in Intermediate- and High-Risk Non-Muscle-Invasive bladder Cancer [J]. Urol Int. 2023;107(6):617\u201323.","journal-title":"Urol Int"},{"issue":"36","key":"3903_CR4","doi-asserted-by":"publisher","first-page":"e30380","DOI":"10.1097\/MD.0000000000030380","volume":"101","author":"W Cao","year":"2022","unstructured":"Cao W, Shao Y, Zou S, et al. Prognostic significance of systemic immune-inflammation index in patients with bladder cancer: A systematic review and meta-analysis [J]. Med (Baltim). 2022;101(36):e30380.","journal-title":"Med (Baltim)"},{"key":"3903_CR5","doi-asserted-by":"crossref","unstructured":"Colak R, Erdem GU, Kapar C et al. Change in the neutrophil-lymphocyte ratio May predict early recurrence in operated bladder cancer [J]. Asia Pac J Clin Oncol. 2024.","DOI":"10.1111\/ajco.14065"},{"key":"3903_CR6","doi-asserted-by":"publisher","first-page":"575483","DOI":"10.3389\/fmolb.2020.575483","volume":"7","author":"X Tang","year":"2020","unstructured":"Tang X, Cao Y, Liu J, et al. Diagnostic value of inflammatory factors in pathology of bladder Cancer patients [J]. Front Mol Biosci. 2020;7:575483.","journal-title":"Front Mol Biosci"},{"issue":"5","key":"3903_CR7","doi-asserted-by":"publisher","first-page":"102144","DOI":"10.1016\/j.clgc.2024.102144","volume":"22","author":"A Salari","year":"2024","unstructured":"Salari A, Ghahari M, Bitaraf M, et al. Prognostic value of NLR, PLR, SII, and dNLR in urothelial bladder Cancer following radical cystectomy [J]. Clin Genitourin Cancer. 2024;22(5):102144.","journal-title":"Clin Genitourin Cancer"},{"issue":"9","key":"3903_CR8","first-page":"1085","volume":"62","author":"ST Yang","year":"2023","unstructured":"Yang ST, Deng C, He BB, et al. [Application of the Chinese expert consensus on diabetes classification in clinical practice] [J]. Zhonghua Nei Ke Za Zhi. 2023;62(9):1085\u201392.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"8","key":"3903_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/hr.2012.56","volume":"35","author":"Y Imai","year":"2012","unstructured":"Imai Y, Kario K, Shimada K, et al. The Japanese society of hypertension guidelines for Self-monitoring of blood pressure at home (Second Edition) [J]. Hypertens Res. 2012;35(8):777\u201395.","journal-title":"Hypertens Res"},{"issue":"4","key":"3903_CR10","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/bju.15757","volume":"130","author":"H Herzberg","year":"2022","unstructured":"Herzberg H, Lifshitz K, Golan S, et al. Association between early change in neutrophil-to-lymphocyte ratio after radical cystectomy and treatment outcomes [J]. BJU Int. 2022;130(4):470\u20137.","journal-title":"BJU Int"},{"issue":"5","key":"3903_CR11","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S1470-2045(22)00158-9","volume":"23","author":"SA Hussain","year":"2022","unstructured":"Hussain SA, Lester JF, Jackson R, et al. Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial [J]. Lancet Oncol. 2022;23(5):650\u20138.","journal-title":"Lancet Oncol"},{"key":"3903_CR12","doi-asserted-by":"crossref","unstructured":"Ivanic D, Dug H, Jagodic S, et al. Preoperative neutrophil-to-lymphocyte ratio (NLR) value as a predictor of recurrence of non-muscle-invasive bladder cancer [J]. Int Urol Nephrol. 2024.","DOI":"10.21203\/rs.3.rs-5210552\/v1"},{"issue":"1","key":"3903_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12894-023-01353-z","volume":"23","author":"H KE","year":"2023","unstructured":"KE H, ZHU L, WANG Q, et al. Neutrophil-to-lymphocyte ratio as a promising non-invasive biomarker for symptom assessment and diagnosis of interstitial cystitis\/bladder pain syndrome [J]. BMC Urol. 2023;23(1):180.","journal-title":"BMC Urol"},{"key":"3903_CR14","doi-asserted-by":"publisher","first-page":"1032907","DOI":"10.3389\/fimmu.2022.1032907","volume":"13","author":"P Liu","year":"2022","unstructured":"Liu P, Chen S, Gao X, et al. Preoperative sarcopenia and systemic immune-inflammation index can predict response to intravesical Bacillus Calmette-Guerin instillation in patients with non-muscle invasive bladder cancer [J]. Front Immunol. 2022;13:1032907.","journal-title":"Front Immunol"},{"key":"3903_CR15","doi-asserted-by":"crossref","unstructured":"Meunier S, Frontczak A, Balssa L et al. Elevated baseline neutrophil count correlates with worse outcomes in patients with Muscle-Invasive bladder Cancer treated with chemoradiation [J]. Cancers (Basel). 2023; 15(6).","DOI":"10.3390\/cancers15061886"},{"issue":"11","key":"3903_CR16","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1007\/s00345-023-04506-9","volume":"41","author":"PL Reignier","year":"2023","unstructured":"Reignier PL, Gauthier H, Hennequin C, et al. Survival after sequential neoadjuvant chemotherapy followed by trimodal treatment or radical cystectomy for muscle-invasive bladder cancer [J]. World J Urol. 2023;41(11):3249\u201355.","journal-title":"World J Urol"},{"issue":"2","key":"3903_CR17","first-page":"339","volume":"5","author":"V Ruiz de Porras","year":"2022","unstructured":"Ruiz de Porras V. Natural bioactive compounds: a potential therapeutic strategy to sensitize bladder cancer to cisplatin treatment? [J]. Cancer Drug Resist. 2022;5(2):339\u201343.","journal-title":"Cancer Drug Resist"},{"key":"3903_CR18","doi-asserted-by":"crossref","unstructured":"Shang B, Hu Z, Xie R, et al. Predictive value of neutrophil extracellular traps in neoadjuvant chemotherapy for Muscle-Invasive bladder Cancer [J]. Mol Carcinog. 2024.","DOI":"10.1002\/mc.23844"},{"issue":"1","key":"3903_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/03915603231203780","volume":"91","author":"R Singh","year":"2024","unstructured":"Singh R, Sharma G, Priyadarshi S, et al. Prognostic significance of preoperative Pyuria & neutrophil to lymphocyte ratio in patients with non-muscle-invasive bladder cancer: A prospective cohort study [J]. Urologia. 2024;91(1):69\u201375.","journal-title":"Urologia"},{"issue":"1","key":"3903_CR20","first-page":"41","volume":"75","author":"D Sudol","year":"2022","unstructured":"Sudol D, Widz D, Mitura P, et al. Neutrophil-to-lymphocyte ratio as a predictor of overall survival and cancer advancement in patients undergoing radical cystectomy for bladder cancer [J]. Cent Eur J Urol. 2022;75(1):41\u20136.","journal-title":"Cent Eur J Urol"},{"key":"3903_CR21","doi-asserted-by":"publisher","first-page":"104236","DOI":"10.1016\/j.critrevonc.2023.104236","volume":"194","author":"N Tripathi","year":"2024","unstructured":"Tripathi N, Fortuna GG, Gebrael G, et al. Predictors of response to neoadjuvant therapy in urothelial cancer [J]. Crit Rev Oncol Hematol. 2024;194:104236.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"3903_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.clgc.2023.01.008","volume":"21","author":"M Von Deimling","year":"2023","unstructured":"Von Deimling M, Schuettfort VM, D\u2019ANDREA D, et al. Predictive and prognostic role of the Neutrophil-to-Lymphocyte ratio in muscle invasive bladder Cancer treated with neoadjuvant chemotherapy and radical cystectomy [J]. Clin Genitourin Cancer. 2023;21(4):430\u201341.","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"3903_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/03936155241261719","volume":"39","author":"X Wang","year":"2024","unstructured":"Wang X, Zhang S, Sun Y, et al. The prognostic significance of preoperative platelet-to-lymphocyte ratio and interleukin-6 level in non-muscle invasive bladder cancer [J]. Int J Biol Markers. 2024;39(3):255\u201364.","journal-title":"Int J Biol Markers"},{"issue":"4","key":"3903_CR24","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1002\/cam4.5284","volume":"12","author":"K Ye","year":"2023","unstructured":"Ye K, Xiao M, Li Z, et al. Preoperative systemic inflammation response index is an independent prognostic marker for BCG immunotherapy in patients with non-muscle-invasive bladder cancer [J]. Cancer Med. 2023;12(4):4206\u201317.","journal-title":"Cancer Med"},{"issue":"7","key":"3903_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.56434\/j.arch.esp.urol.20237607.63","volume":"76","author":"X Zhang","year":"2023","unstructured":"Zhang X, Liu Q. Systemic immune inflammation index and T-Staging predict prognosis in patients with Muscle-Invasive bladder Cancer [J]. Arch Esp Urol. 2023;76(7):511\u20138.","journal-title":"Arch Esp Urol"},{"key":"3903_CR26","doi-asserted-by":"publisher","first-page":"878499","DOI":"10.3389\/fonc.2022.878499","volume":"12","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wang Y, Zhang J, et al. Development of a MRI-Based radiomics nomogram for prediction of response of patients with Muscle-Invasive bladder Cancer to neoadjuvant chemotherapy [J]. Front Oncol. 2022;12:878499.","journal-title":"Front Oncol"},{"issue":"1","key":"3903_CR27","doi-asserted-by":"publisher","first-page":"101671","DOI":"10.1016\/j.adro.2024.101671","volume":"10","author":"GK Harada","year":"2025","unstructured":"Harada GK, Seyedin SN, Heutlinger O, et al. A predictive nomogram for development of lymph node metastasis in Muscle-Invasive bladder Cancer following neoadjuvant therapy [J]. Adv Radiat Oncol. 2025;10(1):101671.","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"3903_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4132\/jptm.2022.11.06","volume":"57","author":"WA Hassan","year":"2023","unstructured":"Hassan WA, Elbanna AK, Noufal N, et al. Significance of tumor-associated neutrophils, lymphocytes, and neutrophil-to-lymphocyte ratio in non-invasive and invasive bladder urothelial carcinoma [J]. J Pathol Transl Med. 2023;57(2):88\u201394.","journal-title":"J Pathol Transl Med"},{"issue":"3","key":"3903_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2217\/bmm-2021-0754","volume":"16","author":"RJ Zhu","year":"2022","unstructured":"Zhu RJ, Zhou J, Liang PQ, et al. Accuracy of cytokeratin 19 fragment in the diagnosis of bladder cancer [J]. Biomark Med. 2022;16(3):197\u2013216.","journal-title":"Biomark Med"},{"key":"3903_CR30","doi-asserted-by":"crossref","unstructured":"Shi Y, Mathis BJ, He Y et al. The current progress and future options of multiple therapy and potential biomarkers for Muscle-Invasive bladder Cancer [J]. Biomedicines. 2023; 11(2).","DOI":"10.3390\/biomedicines11020539"},{"issue":"6","key":"3903_CR31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/dc.24954","volume":"50","author":"J Wang","year":"2022","unstructured":"Wang J, Zhao X, Jiang XL, et al. Diagnostic performance of nuclear matrix protein 22 and urine cytology for bladder cancer: A meta-analysis [J]. Diagn Cytopathol. 2022;50(6):300\u201312.","journal-title":"Diagn Cytopathol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03903-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03903-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03903-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:41:06Z","timestamp":1757220066000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03903-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3903"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03903-1","relation":{},"ISSN":["1477-7819"],"issn-type":[{"type":"electronic","value":"1477-7819"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"1 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Shandong Provincial Hospital Affiliated to Shandong First Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study. Participants were informed about the purpose of the study, procedures involved, potential risks, and benefits, and their right to withdraw at any time without penalty. Written consent was obtained from all participants prior to their participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"274"}}